J&J | JNJ
Stock Price
142.15
Daily Change
-4.02 -2.75%
Monthly
-4.99%
Yearly
-12.00%
Q1 Forecast
141.52



Peers Price Chg Day Year Date
AbbVie 178.00 -1.97 -1.09% 10.26% Jan/08
Abbott 113.95 0.57 0.50% 1.08% Jan/08
Amgen 262.51 0.32 0.12% -15.56% Jan/08
AstraZeneca 10,754.00 86.00 0.81% -1.36% Jan/08
Baxter International 29.75 0.14 0.47% -26.86% Jan/08
Bayer 19.67 -0.12 -0.61% -44.75% Jan/08
Becton, Dickinson and Co. 234.16 1.90 0.82% -5.48% Jan/08
Biogen 152.07 -1.24 -0.81% -41.06% Jan/08
Bristol-Myers Squibb 56.62 -0.62 -1.08% 9.33% Jan/08
Boston Scientific 96.38 4.43 4.81% 62.72% Jan/08
CONMED 68.54 -0.01 -0.01% -38.57% Jan/08
Cooper Companies 92.30 -0.41 -0.44% -1.20% Jan/08
Dexcom 80.13 0.81 1.02% -38.19% Jan/08
Edwards Lifesciences 74.18 0.47 0.63% -1.98% Jan/08
Gilead Sciences 89.51 -1.12 -1.24% 4.01% Jan/08
Globus Medical 86.16 2.71 3.24% 60.02% Jan/08
GlaxoSmithKline 1,360.00 2.50 0.18% -13.72% Jan/08
Hologic 73.12 0.43 0.59% 1.39% Jan/08
Integra LifeSciences 22.23 0.08 0.36% -48.85% Jan/08
Indivior 976.00 -8.00 -0.81% -19.34% Jan/08
Intuitive Surgical 543.21 11.31 2.13% 65.18% Jan/08
J&J 142.15 -4.02 -2.75% -12.00% Jan/08
Eli Lilly 787.69 13.71 1.77% 25.93% Jan/08
Medtronic 83.06 3.26 4.09% -4.15% Jan/08
Merit Medical Systems 98.07 2.21 2.30% 25.74% Jan/08
Merck 99.87 -1.21 -1.20% -14.92% Jan/08
Novartis 90.96 0.57 0.63% -0.20% Jan/08
Pfizer 26.96 -0.14 -0.52% -8.86% Jan/08
Insulet 270.49 4.84 1.82% 32.15% Jan/08
Regeneron Pharmaceuticals 738.72 7.73 1.06% -18.16% Jan/08
Roche Holding 266.90 2.50 0.95% 5.81% Jan/08
Sanofi 95.67 -0.18 -0.19% 0.50% Jan/08
Stryker 364.09 8.94 2.52% 20.06% Jan/08
Teva Pharmaceutical Industries 7,917.00 44.00 0.56% 88.19% Jan/08
Tandem Diabetes Care 37.30 0.25 0.67% 32.69% Jan/08
Vertex Pharmaceuticals 411.51 2.90 0.71% -2.26% Jan/08
Zimmer Biomet Holdings 101.09 -2.02 -1.96% -17.05% Jan/08
Zoetis 164.93 -0.87 -0.52% -15.92% Jan/08

Indexes Price Day Year Date
US500 5911 2.43 0.04% 24.28% Jan/08
US30 42472 -56.13 -0.13% 13.18% Jan/08

Johnson & Johnson traded at $141.72 this Wednesday January 8th, decreasing $4.45 or 3.04 percent since the previous trading session. Looking back, over the last four weeks, J&J lost 5.27 percent. Over the last 12 months, its price fell by 12.26 percent. Looking ahead, we forecast Johnson & Johnson to be priced at 141.52 by the end of this quarter and at 132.88 in one year, according to Trading Economics global macro models projections and analysts expectations.

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.